On 4th October 2021 the US Food and Drug Administration (FDA) issued two final rules providing additional information on the requirements for Premarket Tobacco Product Applications (PMTAs) and Substantial Equivalence (SE) reports. This report aims to answer questions that may be raised on this topic, in particular taking into account the public comments and responses the FDA has offered.
...Written by Berta Camps Bisbal || 3rd November 2021 || Regulatory reports || FDA | Marketing and Retailing | Policy and Politics | Regulation and Legislation | Tax | North America United States
Free Sample